UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
September 2, 2016
Accession Number:
0001193125-16-696706
Submission Type:
POS AM
CIK:
0001369786
Company Name:
Sagent Pharmaceuticals, Inc.
File Number:
333-200027